|
US20080220025A1
(en)
*
|
1995-03-17 |
2008-09-11 |
James Thompson |
Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
|
|
US7361332B2
(en)
*
|
1995-03-17 |
2008-04-22 |
The Regents Of The University Of California |
Treating tumors using implants comprising combinations of allogeneic cells
|
|
AU7154598A
(en)
*
|
1997-04-23 |
1998-11-13 |
Regents Of The University Of California, The |
A cell strain with activated anti-cancer cytotoxic activity
|
|
ATE359080T1
(de)
|
1997-10-10 |
2007-05-15 |
Univ California |
Allogene zellkombination enthaltende implantate zur krebsbehandlung
|
|
AU9794698A
(en)
|
1997-10-10 |
1999-05-03 |
Regents Of The University Of California, The |
Enhanced immunogenic cell populations prepared using h2 receptor antagonists
|
|
AU9589398A
(en)
|
1997-10-10 |
1999-05-03 |
Applied Immunotherapeutics, Inc. |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
|
|
JP4389039B2
(ja)
*
|
1998-04-09 |
2009-12-24 |
株式会社リンフォテック |
アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット
|
|
US7666609B1
(en)
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
|
ATE407695T1
(de)
|
1999-02-09 |
2008-09-15 |
Riken |
Tumorimpfstoff
|
|
WO2001075073A2
(en)
|
2000-04-01 |
2001-10-11 |
Onyvax Limited |
Prostate cell lines and their use
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
DE10043437A1
(de)
*
|
2000-09-04 |
2002-03-28 |
Horst Lindhofer |
Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites
|
|
US20040191246A1
(en)
|
2003-02-26 |
2004-09-30 |
Connelly Patrick R. |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
MXPA03010278A
(es)
*
|
2001-05-11 |
2004-12-06 |
Wellstat Biologics Corp |
Terapia con virus oncolitico.
|
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
AU2002365538A1
(en)
*
|
2001-11-27 |
2003-06-10 |
Nexyte Ab |
Production of eukaryotic proteins and nucleic acid molecules in c. elegans
|
|
KR20020060643A
(ko)
*
|
2002-06-04 |
2002-07-18 |
김진경 |
타인의 면역시스템을 이용하는 암의 치료 방법
|
|
EP2363710B1
(en)
*
|
2002-08-08 |
2015-07-01 |
Baylor College Of Medicine |
Isolation and identification of T cells
|
|
US7571817B2
(en)
*
|
2002-11-06 |
2009-08-11 |
Varco I/P, Inc. |
Automatic separator or shaker with electromagnetic vibrator apparatus
|
|
WO2004096244A1
(en)
*
|
2003-05-02 |
2004-11-11 |
Md Bioalpha Co. Ltd. |
Method of preparing tumor vaccine for the inducement of anti-tumor activity and a pharmaceutical composition containing the same
|
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
|
JP5049011B2
(ja)
|
2003-06-11 |
2012-10-17 |
ザ ユニバーシティー オブ シカゴ |
変異体ｌｉｇｈｔによるｔ細胞腫瘍浸潤の増大
|
|
US20050019336A1
(en)
|
2003-07-23 |
2005-01-27 |
Dalgleish Angus George |
Human prostate cell lines in cancer treatment
|
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
|
EP2450433A3
(en)
*
|
2003-10-08 |
2012-08-08 |
Vet-Stem Inc |
Methods of preparing and using stem cell compositions and kits comprising the same
|
|
US8029454B2
(en)
*
|
2003-11-05 |
2011-10-04 |
Baxter International Inc. |
High convection home hemodialysis/hemofiltration and sorbent system
|
|
US20050112684A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Eric Holzle |
Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners
|
|
ES2383306T3
(es)
|
2004-02-03 |
2012-06-20 |
The Regents Of The University Of Michigan |
Composiciones para el tratamiento del cáncer de mama y de páncreas
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
US8257715B1
(en)
|
2004-08-26 |
2012-09-04 |
University Of Notre Dame |
Tissue vaccines and uses thereof
|
|
US9155789B2
(en)
*
|
2005-04-25 |
2015-10-13 |
New York University |
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
|
|
US20090162405A1
(en)
*
|
2006-12-14 |
2009-06-25 |
Yong Qian |
Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
|
|
US8778362B2
(en)
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
|
|
US8802113B2
(en)
*
|
2005-10-27 |
2014-08-12 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US9308252B2
(en)
*
|
2005-10-27 |
2016-04-12 |
Cook Biotech, Inc. |
Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
|
|
US8778360B2
(en)
*
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US7723112B2
(en)
*
|
2005-10-31 |
2010-05-25 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
PT2500360E
(pt)
|
2005-10-31 |
2015-10-15 |
Oncomed Pharm Inc |
Composições e métodos para diagnóstico e tratamento do cancro
|
|
WO2007100640A2
(en)
*
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
PT2420833E
(pt)
*
|
2006-05-05 |
2015-11-24 |
Opexa Therapeutics |
Vacina de células t
|
|
WO2008019290A2
(en)
|
2006-08-04 |
2008-02-14 |
Astrazeneca Ab |
Human antibodies to erbb 2
|
|
US7972594B2
(en)
*
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
|
CN101626781B
(zh)
*
|
2006-11-22 |
2011-10-12 |
刘华 |
制备具有抗肿瘤免疫应答反应的细胞群的方法
|
|
US20080147007A1
(en)
*
|
2006-12-19 |
2008-06-19 |
Toby Freyman |
Delivery device with pressure control
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CA2676143A1
(en)
|
2007-01-26 |
2008-07-31 |
University Of Louisville Research Foundation, Inc. |
Modification of exosomal components for use as a vaccine
|
|
WO2008098183A2
(en)
*
|
2007-02-08 |
2008-08-14 |
The University Of Chicago |
Combination therapy for treating cancer
|
|
US8263081B2
(en)
|
2007-05-14 |
2012-09-11 |
The University Of Chicago |
Antibody-light fusion products for cancer therapeutics
|
|
US8741315B2
(en)
*
|
2007-09-12 |
2014-06-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
|
US8114276B2
(en)
|
2007-10-24 |
2012-02-14 |
Baxter International Inc. |
Personal hemodialysis system
|
|
US9283266B2
(en)
*
|
2008-02-28 |
2016-03-15 |
University Of Notre Dame |
Metastasis inhibition preparations and methods
|
|
ES2663536T3
(es)
|
2008-09-26 |
2018-04-13 |
Oncomed Pharmaceuticals, Inc. |
Agentes que se unen a receptores frizzled y usos de los mismos
|
|
CA2779436A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
KR101588547B1
(ko)
|
2008-11-11 |
2016-01-28 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
항-ｃｘｃｒ１ 조성물 및 방법
|
|
CU23740A1
(es)
*
|
2009-09-29 |
2011-12-28 |
Ct Ingenieria Genetica Biotech |
Método de obtención de una formulación de antígenos del virus de la hepatitis b
|
|
EP2494038B1
(en)
*
|
2009-10-27 |
2019-06-26 |
Immunicum AB |
Method for proliferation of antigen-specific t cells
|
|
US8846059B2
(en)
|
2009-12-08 |
2014-09-30 |
University Of Notre Dame |
Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
|
|
BR112012013780B8
(pt)
*
|
2009-12-08 |
2021-07-27 |
Univ Illinois |
biorreator para modular linfócitos e suprimir células t autorreativas, sistema para inibição de um distúrbio autoimune, e, método ativar células t reguladoras
|
|
US20110150934A1
(en)
*
|
2009-12-18 |
2011-06-23 |
University Of Notre Dame |
Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
EP3450979A3
(en)
|
2010-03-17 |
2019-04-24 |
The Regents of The University of Michigan |
Using phage epitopes to profile the immune response
|
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
KR20130055591A
(ko)
*
|
2010-04-13 |
2013-05-28 |
가부시키가이샤 르네상스 에너지 인베스트먼트 |
암 조직 유래 세포괴 또는 암 세포 응집괴로부터 얻어지는 암 치료용 조성물과 그것을 이용한 면역요법제의 제조 방법 및 면역요법 효과 평가 방법
|
|
PH12013502253A1
(en)
|
2011-05-03 |
2019-11-29 |
Immunovative Therapies Ltd |
Methods for handling biological drugs containing living cells
|
|
HRP20250981T1
(hr)
*
|
2011-05-24 |
2025-10-24 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
|
CN104284680A
(zh)
|
2011-12-15 |
2015-01-14 |
芝加哥大学 |
使用对受体的亲和力增加的突变型light分子用于癌症治疗的方法和组合物
|
|
HK1212216A1
(en)
|
2012-10-23 |
2016-06-10 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
JP2016532717A
(ja)
*
|
2013-09-27 |
2016-10-20 |
ヴァクシノゲン インターナショナル パートナーズ， エルピーＶａｃｃｉｎｏｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐａｒｔｎｅｒｓ， Ｌｐ |
自己腫瘍ワクチン及び方法
|
|
CN119345231A
(zh)
|
2014-11-05 |
2025-01-24 |
纪念斯隆-凯特林癌症中心 |
选择用于过继细胞疗法的t细胞系及其供体的方法
|
|
US20180055920A1
(en)
*
|
2015-03-12 |
2018-03-01 |
University Of Iowa Research Foundation |
Vaccine, therapeutic composition and methods for treating or inhibiting cancer
|
|
EP3756676B1
(en)
*
|
2015-06-26 |
2023-01-11 |
Memorial Sloan Kettering Cancer Center |
Methods of treating cmv retinitis by t cell therapy
|
|
IL295616A
(en)
|
2015-07-31 |
2022-10-01 |
Us Health |
Adapted cells and treatment methods
|
|
US11219645B2
(en)
|
2015-11-18 |
2022-01-11 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
WO2018138682A1
(en)
|
2017-01-26 |
2018-08-02 |
Immune Therapeutics |
Methods and compositions useful for treating cancer
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
KR102256337B1
(ko)
*
|
2017-10-17 |
2021-05-26 |
(주)노터스생명과학 |
조직이식을 위한 세포배양액을 포함하는 면역억제제
|
|
US11446329B2
(en)
|
2017-11-01 |
2022-09-20 |
Restem Llc |
Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
FR3082730B1
(fr)
*
|
2018-06-21 |
2022-04-22 |
Med Inn Pharma |
Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique
|
|
US20250231177A1
(en)
*
|
2022-04-04 |
2025-07-17 |
University Of Florida Research Foundation, Inc. |
Method of characterizing tumors
|
|
CN114984199A
(zh)
*
|
2022-04-19 |
2022-09-02 |
苏州尔生生物医药有限公司 |
一种基于癌症特异性t细胞的细胞系统、淋巴细胞药物及其应用
|